>
>
Aesthetic Injectables Market - By Type {Botulinum Toxin, Dermal Fillers (Product [Hyaluronic Acid, Calcium Hydroxyapatite], Application (Face Lift, Wrinkle Reduction)}, Gender, Age Group, End-user & Forecast2024 – 2032
Download Free PDF

Aesthetic Injectables Market
Get a free sample of this reportGet a free sample of this report Aesthetic Injectables Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Buy now
Premium Report Details
Base Year: 2023
Companies covered: 12
Tables & Figures: 430
Countries covered: 19
Pages: 240
Download Free PDF
Aesthetic Injectables Market Size
Aesthetic Injectables Market was valued at USD 13.2 billion in 2023 and is anticipated to showcase a growth of 10.2% to reach USD 31.3 billion by 2032. Aesthetic injectables refer to non-surgical cosmetic procedures that involve injecting substances into the skin to enhance or alter its appearance. These procedures are often performed for aesthetic purposes to address concerns such as wrinkles, fine lines, volume loss, and facial contouring among others.
The growth of the aesthetic injectables market is propelled by several factors, including the increasing aging population seeking non-surgical solutions for signs of aging, rising beauty consciousness across age groups, ongoing technological advancements for improving product safety and efficacy, and the minimally invasive nature of these procedures. According to International Society of Aesthetic Plastic Surgery, around 7.3 million non-surgical botulinum toxin procedures were performed. Thus, the growing awareness of aesthetic procedures and the availability of non-surgical options have contributed to an expanding patient base seeking injectable treatments.
Aesthetic Injectables Market Trends
Aesthetic Injectables Market Analysis
The market based on type, is categorized into botulinum toxin and dermal fillers. The botulinum toxin segment is expected to reach USD 16.8 billion by 2032. The botulinum toxin segment is further sub-categorized into botulinum toxin A and botulinum toxin B.
The aesthetic injectables market, by gender is segmented into female and male. In 2023, female segment accounted for 93.2%.
By age group, the market is divided into 15 – 30, 31 – 40, 41 – 50, 51 – 60, >60. Among the age groups, 41 – 50 segment dominated the market and is expected to grow at CAGR of 10.5%.
The aesthetic injectables market, by end-user is classified into hospitals, dermatology clinics, and other end-users. The dermatology clinics segment dominated the market in 2023 and is expected to reach USD 15.3 billion by 2032.
North America market accounted for USD 7.5 billion revenue in 2023 and is projected to reach USD 16.5 billion over the analysis timeline.
Aesthetic Injectables Market Share
The aesthetic injectables industry is dynamic and competitive, driven by a combination of innovation, strategic collaborations, global expansion efforts, and a commitment to regulatory compliance. Companies such as Allergan (now part of AbbVie), Galderma, and Merz Pharma are notable players, with well-established product portfolios that include popular dermal fillers and botulinum toxin products.
Aesthetic Injectables Market Companies
Prominent players operating in the aesthetic injectables industry include:
Aesthetic Injectables Industry News
The aesthetic injectables market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 – 2032 for the following segments:
Click here to Buy Section of this Report
Market, By Type
Market, By Gender
Market, By Age Group
Market, By End-user
The above information is provided for the following regions and countries: